Mexico vs Türkiye: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- Mexico
- Türkiye
How they compare
Mexico currently reports 18,895 Cases against 132 Cases in Türkiye, a difference of 18,763 Cases.
That makes Mexico's figure about 143.1 times Türkiye's.
Across all 42 years both countries report, Mexico has been ahead every year.
Mexico ranks 2nd and Türkiye ranks 3rd of 34 countries.
Mexico has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Mexico | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 1,140 Cases | 4.29 Cases | 1,135 Cases | Mexico |
| 1990s | 5,478 Cases | 28.8 Cases | 5,449 Cases | Mexico |
| 2000s | 10,633 Cases | 45.5 Cases | 10,588 Cases | Mexico |
| 2010s | 13,540 Cases | 101.5 Cases | 13,439 Cases | Mexico |
| 2020s | 16,433 Cases | 84.4 Cases | 16,349 Cases | Mexico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Mexico or Türkiye?
- Mexico, at 18,895 Cases against 132 Cases in Türkiye as of 2024.
- What is the difference in communicable diseases — communicable disease incidence between Mexico and Türkiye?
- 18,763 Cases, with Mexico ahead.
- How many years of comparable data are there for Mexico and Türkiye?
- 42 years are reported by both, from 1983 to 2024.
- How do Mexico and Türkiye rank globally for communicable diseases — communicable disease incidence?
- Mexico ranks 2nd and Türkiye ranks 3rd of 34 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.